Discovery of medium ring thiophosphorus based heterocycles as antiproliferative agents

Hydrogen sulfide (H₂S) has been investigated for its potential in therapy. Recently, we reported novel H₂S donor molecules based on a thiophosphorus core, which slowly release H₂S and have improved anti-proliferative activity in cancer cell lines compared to the most widely studied H₂S donor GYY4137 (1). Herein, we have prepared new thiophosphorus organic H₂S donors with different ring sizes and evaluated them in two solid tumor cell lines and one normal cell line. A seven membered ring compound, 17, was found to be the most potent with sub-micromolar IC_50s in breast (0.76μM) and ovarian (0.76μM) cancer cell lines. No significant H₂S release was detected in aqueous solution for this compound. However, confocal imaging showed that H₂S was released from 17 inside cells at a similar level to the widely studied H₂S donor GYY4137, which was shown to release 10μM H₂S after 12h at a concentration of 400μM. Comparison of 17 with its non-sulfur oxygen analogue, 26, provided evidence that the sulfur atom is important for its potency. However, the significant potency observed for 26 (5.94-11.0μM) indicates that the high potency of 17 is not entirely due to release of H₂S. Additional mechanism(s) appear to be responsible for the observed activity, hence more detailed studies are required to better understand the role of H₂S in cancer with potent thiophosphorus agents.